Previous 10 | Next 10 |
New York, New York--(Newsfile Corp. - December 9, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential misconduct at Penumbra, Inc. ("Penumbra" or the "Company") (NYSE:PEN). The investigation focuses on w...
Nationally ranked litigation firm Labaton Sucharow announces investigation of Penumbra, Inc. ("Penumbra" Or The "Company") (NYSE: PEN) and encourages investors with losses to contact the Firm. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United Stat...
,Responding to allegations made by Quintessential Capital Management, Penumbra, Inc. (NYSE:PEN) confirms that the papers rumored to be authored by Antik Bose are attributed to Dr. Arani Bose, the company’s chief innovator/co-founder. “Dr. Arani Bose has co-au...
Penumbra Responds to False Allegations from Short Sellers Seeking to Manipulate Company Stock and Remove Life-saving Medical Devices from the Market ALAMEDA, Calif. , Dec. 8, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovati...
Quintessential Capital Management continues to attack Penumbra, Inc. (NYSE:PEN). Releasing its latest research report on the company, the short seller alleges that a large portion of its scientific literature has been produced by a ‘fake character’.The report adds, ...
Gainers: Curis (CRIS) +335%.Lexicon Pharmaceuticals (LXRX) +97%.Mammoth Energy Services (TUSK) +61%.NeuroMetrix (NURO) +49%.Stitch Fix (SFIX) +45%.IGM Biosciences (IGMS) +38%.Blonder Tongue Laboratories (BDR) +26%.Infinity Pharmaceuticals (INFI) +25%.KLX Energy Services (KLXE) +24%....
Shares of Penumbra (NYSE: PEN) were plunging 13.1% lower as of 11:50 a.m. EST on Tuesday. The decline came following short-seller Quintessential Capital Management's (QCM) online release of a scathing report about the healthcare company. QCM alleged today that some of Penumbra's...
Penumbra, Inc. to Participate in CEO Discussion with Bank of America ALAMEDA, Calif. , Dec. 4, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its chief executive officer is scheduled to participate in a discussion with Bank of America on Tues...
The FDA has announced 510(k) clearance for expanded indication of the latest iteration of Penumbra's ([[PEN]] +1.3%) Indigo Aspiration System, Lightning 12.As part of the Indigo Aspiration System, Lightning 12 and Separator 12 are now indicated for the removal of fresh, soft emboli and thromb...
Lightning 12 and Separator 12 Now Indicated for Treatment of PE Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the latest iteration of the ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...